Anti-mouse CD52 monoclonal antibody ameliorates iron-deficient anaemia in IL-10 knockout mice (Q43735862)

26 November 2017

title

Anti-mouse CD52 monoclonal antibody ameliorates iron-deficient anaemia in IL-10 knockout mice (English)

1 reference

26 November 2017

0 references

Honggang Wang

1

1 reference

26 November 2017

Jianning Dong

2

1 reference

26 November 2017

Lugen Zuo

3

1 reference

26 November 2017

Jianhui Liu

4

1 reference

26 November 2017

Weiming Zhu

5

1 reference

26 November 2017

Yi Li

6

1 reference

26 November 2017

Lili Gu

7

1 reference

26 November 2017

Jie Zhao

8

1 reference

26 November 2017

Liang Zhang

9

1 reference

26 November 2017

Jianfeng Gong

10

1 reference

26 November 2017

Wei Zhang

11

1 reference

26 November 2017

Ning Li

12

1 reference

26 November 2017

Jieshou Li

13

1 reference

26 November 2017

publication date

28 October 2013

1 reference

British Journal of Nutrition

26 November 2017

published in

1 reference

26 November 2017

volume

111

1 reference

26 November 2017

issue

6

1 reference

26 November 2017

page(s)

987-995

1 reference

Iron regulation by hepcidin

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Tumor necrosis factor α inhibits expression of the iron regulating hormone hepcidin in murine models of innate colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Rapid development of colitis in NSAID-treated IL-10-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Iron status, anemia, and plasma erythropoietin levels in acute and chronic mouse models of colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

The pleiotropic effects of erythropoietin in infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Erythropoietin reduces the development of experimental inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Effect of anti-mouse CD52 monoclonal antibody on mouse intestinal intraepithelial lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

What's the next best cytokine target in IBD?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Intestinal homeostasis and its breakdown in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Two to tango: regulation of Mammalian iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Interleukin-10-deficient mice develop chronic enterocolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Regulation and functions of the IL-10 family of cytokines in inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

7 January 2021

Antimouse CD52 monoclonal antibody inhibits established spontaneous colitis in IL-10-deficient mice

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

7 January 2021

Recombinant human erythropoietin in patients with inflammatory bowel disease and refractory anemia: a 15-year single center experience

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

7 January 2021

Attenuation of colonic inflammation by partial replacement of dietary linoleic acid with α-linolenic acid in a rat model of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

7 January 2021

Diagnosis and management of iron deficiency anemia in patients with IBD.

1 reference

https://api.crossref.org/works/10.1017%2FS0007114513003413

7 January 2021

https://api.crossref.org/works/10.1017%2FS0007114513003413

1 reference

7 January 2021

10.1017/S0007114513003413

Identifiers

DOI

1 reference

26 November 2017

1 reference